European Healthtech startup funding raised during H1 2023.
In H1 2023, 302 European Healthtech companies raised a combined €3.0B across 309 funding rounds, down 35.5% versus H1 2022. UK led by capital raised, and European Innovation Council (EIC) was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Evotec | Debt | Feb 2023 | €150M |
| DistalMotion | Other | Apr 2023 | €137M |
| Amolyt Pharma | Series C | Jan 2023 | €129M |
| Hemab Therapeutics | Series B | Feb 2023 |
23 exits · €246M disclosed.
| Verogen | Acquisition | Jan 2023 | €140M |
| Odin Vision | Acquisition | Jun 2023 | €77M |
| Diamond Whites | Acquisition | Feb 2023 | €30M |
| €127M |
| Ascend | Other | May 2023 | €121M |
| Noema Pharma | Series B | Mar 2023 | €105M |
| Patient21 | Series C | May 2023 | €100M |
| Humble | Other | Jun 2023 | €74M |
| Complement Therapeutics | Series A | Apr 2023 | €72M |
| Corwave | Series C | Jun 2023 | €61M |
| SoniVie | Series C | Jan 2023 | €56M |
| Moon Surgical | Other | May 2023 | €51M |
| Tissium | Series D+ | May 2023 | €50M |
| NewBiologix | Series A | May 2023 | €46M |
| Grey Wolf Therapeutics | Series B | Jan 2023 | €45M |
